Lengauer T - Search Results

1

Improved therapy-success prediction with GSS estimated from clinical HIV-1 sequences.

Pironti A, Pfeifer N, Kaiser R, Walter H, Lengauer T. Pironti A, et al. Among authors: lengauer t. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19743. doi: 10.7448/IAS.17.4.19743. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397488 Free PMC article.

2

Only slight impact of predicted replicative capacity for therapy response prediction.

Weisser H, Altmann A, Sierra S, Incardona F, Struck D, Sönnerborg A, Kaiser R, Zazzi M, Tschochner M, Walter H, Lengauer T. Weisser H, et al. Among authors: lengauer t. PLoS One. 2010 Feb 3;5(2):e9044. doi: 10.1371/journal.pone.0009044. PLoS One. 2010. PMID: 20140263 Free PMC article.

3

Improving HIV coreceptor usage prediction in the clinic using hints from next-generation sequencing data.

Pfeifer N, Lengauer T. Pfeifer N, et al. Among authors: lengauer t. Bioinformatics. 2012 Sep 15;28(18):i589-i595. doi: 10.1093/bioinformatics/bts373. Bioinformatics. 2012. PMID: 22962486 Free PMC article.

4

Association between HIV-1 coreceptor usage and resistance to broadly neutralizing antibodies.

Pfeifer N, Walter H, Lengauer T. Pfeifer N, et al. Among authors: lengauer t. J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):107-12. doi: 10.1097/QAI.0000000000000283. J Acquir Immune Defic Syndr. 2014. PMID: 25072615 Free PMC article.

5

Effects of sequence alterations on results from genotypic tropism testing.

Pironti A, Sierra S, Kaiser R, Lengauer T, Pfeifer N. Pironti A, et al. Among authors: lengauer t. J Clin Virol. 2015 Apr;65:68-73. doi: 10.1016/j.jcv.2015.02.006. Epub 2015 Feb 10. J Clin Virol. 2015. PMID: 25766992 Free article.

6

Parameters Influencing Baseline HIV-1 Genotypic Tropism Testing Related to Clinical Outcome in Patients on Maraviroc.

Sierra S, Dybowski JN, Pironti A, Heider D, Güney L, Thielen A, Reuter S, Esser S, Fätkenheuer G, Lengauer T, Hoffmann D, Pfister H, Jensen B, Kaiser R. Sierra S, et al. Among authors: lengauer t. PLoS One. 2015 May 13;10(5):e0125502. doi: 10.1371/journal.pone.0125502. eCollection 2015. PLoS One. 2015. PMID: 25970632 Free PMC article.

7

Determination of Phenotypic Resistance Cutoffs From Routine Clinical Data.

Pironti A, Walter H, Pfeifer N, Knops E, Lübke N, Büch J, Di Giambenedetto S, Kaiser R, Lengauer T; EuResist Network Study Group. Pironti A, et al. Among authors: lengauer t. J Acquir Immune Defic Syndr. 2017 Apr 15;74(5):e129-e137. doi: 10.1097/QAI.0000000000001198. J Acquir Immune Defic Syndr. 2017. PMID: 27787339 Free PMC article.

8

A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support.

Döring M, Borrego P, Büch J, Martins A, Friedrich G, Camacho RJ, Eberle J, Kaiser R, Lengauer T, Taveira N, Pfeifer N. Döring M, et al. Among authors: lengauer t. Retrovirology. 2016 Dec 20;13(1):85. doi: 10.1186/s12977-016-0320-7. Retrovirology. 2016. PMID: 27998283 Free PMC article.

9

Using drug exposure for predicting drug resistance - A data-driven genotypic interpretation tool.

Pironti A, Pfeifer N, Walter H, Jensen BO, Zazzi M, Gomes P, Kaiser R, Lengauer T. Pironti A, et al. Among authors: lengauer t. PLoS One. 2017 Apr 10;12(4):e0174992. doi: 10.1371/journal.pone.0174992. eCollection 2017. PLoS One. 2017. PMID: 28394945 Free PMC article.

10

Results of the first international HIV-1 coreceptor proficiency panel test.

Heger E, Kaiser R, Knops E, Neumann-Fraune M, Schuelter E, Pironti A, Lengauer T, Walter H, Sierra S. Heger E, et al. Among authors: lengauer t. J Clin Virol. 2017 Aug;93:53-56. doi: 10.1016/j.jcv.2017.06.002. Epub 2017 Jun 10. J Clin Virol. 2017. PMID: 28633097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters